A Case Report on Iatrogenic Cushing Syndrome with Diabetes Mellitus

Authors

  • Aashutosh Sinwal Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017 https://orcid.org/0000-0003-1792-6355
  • Aman Kushwaha Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017
  • Gyan Ranjan Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017
  • Ratana RAM Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017
  • Kalpana Upadhayay Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017
  • Mukesh Choudhary Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017
  • Mudit Bhardwaj Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Abstract

Cushing syndrome (CS) is a condition caused due to high levels of cortisol in which weight gain and fat tissue build-up take place. Generally, patients with Cushing syndrome also suffer from diabetes. A 57-year-old female patient with aggravated cortisol levels. Laboratory investigations of the patient were performed and they showed decreased haemoglobin levels, but increased vitamin B12 levels, and TSH levels. The patient was prescribed a combination of medications to manage anemia, anemia, and diabetes. The patient's medical history included splenomegaly, cholelithiasis, panniculitis, and kidney enlargement. The patient's diabetes was responding well to the treatment and was better after 10 days.

Keywords: Cushing syndrome, Diabetes mellitus, corticosteroid.

Keywords:

Cushing syndrome, Diabetes mellitus, corticosteroid

DOI

https://doi.org/10.22270/jddt.v14i2.6421

Author Biographies

Aashutosh Sinwal, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Aman Kushwaha, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Gyan Ranjan, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Ratana RAM, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Kalpana Upadhayay, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Mukesh Choudhary, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Mudit Bhardwaj, Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

Pharm D, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India,302017

References

Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021 Nov;69(11):2932-2938. http://dx.doi.org/10.4103/ijo.IJO_1627_21 . PMID: 34708726; PMCID: PMC8725109.

Sever, M. S., & Vanholder, R. Management of crush syndrome casualties after disasters. Rambam Maimonides medical journal, 2011;2(2):e0039. https://doi.org/10.5041/RMMJ.10039. PMid:23908797 PMCid:PMC3678930

Hegedüs, Laszlo et al. “Primary hypothyroidism and quality of life.” Nature reviews. Endocrinology vol. 2022;18(4):230-242. http://dx.doi.org/10.1038/s41574-021-00625-8 . PMid:35042968 PMCid:PMC8930682

Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. Diagnosis and management of adrenal insufficiency. The Lancet. Diabetes & Endocrinology, 2015;3(3):216–226. https://doi.org/10.1016/s2213-8587(14)70142-1 PMid:25098712

Kang J-S, Lee M-H. Overview of therapeutic drug monitoring. Korean J Intern Med [Internet]. 2009;24(1):1. http://dx.doi.org/10.3904/kjim.2009.24.1.1. PMid:19270474 PMCid:PMC2687654

Kairys N, Anastasopoulou C, Schwell A. Cushing Disease. StatPearls Publishing; 2023.

International Diabetes Federation. IDF Diabetes Atlas. 2019.

Higgins T. HbA1c for screening and diagnosis of diabetes mellitus. Endocrine. 2013 Apr;43(2):266-73. http://dx.doi.org/10.1007/s12020-012-9768-y . PMID:22907625.

Munir A, Newell-Price J. Management of diabetes mellitus in Cushing’s syndrome. Neuroendocrinology. 2010 Sep 1;92(Suppl. 1):82-5. https://doi.org/10.1159/000314316 PMid:20829624

Published

15-02-2024
Statistics
Abstract Display: 159
PDF Downloads: 179
PDF Downloads: 15

How to Cite

1.
Sinwal A, Kushwaha A, Ranjan G, RAM R, Upadhayay K, Choudhary M, et al. A Case Report on Iatrogenic Cushing Syndrome with Diabetes Mellitus. J. Drug Delivery Ther. [Internet]. 2024 Feb. 15 [cited 2025 Feb. 13];14(2):14-5. Available from: https://jddtonline.info/index.php/jddt/article/view/6421

How to Cite

1.
Sinwal A, Kushwaha A, Ranjan G, RAM R, Upadhayay K, Choudhary M, et al. A Case Report on Iatrogenic Cushing Syndrome with Diabetes Mellitus. J. Drug Delivery Ther. [Internet]. 2024 Feb. 15 [cited 2025 Feb. 13];14(2):14-5. Available from: https://jddtonline.info/index.php/jddt/article/view/6421

Most read articles by the same author(s)